Description
| Product Name | CAT.No | Size |
| Tumour Marker Control Level 1 | BXC0792A | 5 x 2ml |
| Tumour Marker Control Level 2 | BXC0792B | 5 x 2ml |
| Tumour Marker Control Level 3 | BXC0792C | 5 x 2ml |
| Tumour Marker Control Set Level 1 – 3 | BXC0793A | 3 x 1 x 2ml |
Product Description
The Biorex Diagnostics Tumour Marker Control kits provide human serum–based, ready-to-use materials for accurate quality control of multiple tumour marker assays, including AFP, CEA, CA-125, CA-19.9, CA-15-3, Ferritin, ß2-Microglobulin, PSA, FßhCG, and Thyroglobulin. These controls ensure precision, reproducibility, and reliability in clinical laboratories, supporting early cancer detection, treatment monitoring, and patient management.
Key Features
• Human serum–based – closely mimics patient samples for clinically relevant testing
• Multiple control levels – low, normal, and high levels to assess assay performance across clinically relevant ranges
• Liquid-stable formulation – ready-to-use for convenience and consistent results
• Wide compatibility – suitable for immunoassays on all major automated and semi-automated analysers
• Precision and accuracy assessment – monitors assay reproducibility across runs and instruments
Benefits
Routine use enables laboratories to maintain high-quality standards in tumour marker testing, detect assay variations early, and ensure compliance with ISO 15189, CAP, and CLIA standards. These controls provide confidence in tumour marker measurements, supporting reliable diagnosis, prognosis, treatment evaluation, and improved patient outcomes.